#USA #New York #Class Action #The Gross Law Firm #Biohaven Ltd.

Important Notice for Biohaven Ltd. Shareholders

On September 4, 2025, The Gross Law Firm announced crucial news for shareholders of Biohaven Ltd. (NYSE: BHVN). Specifically, they are urging individuals who bought shares during a designated period to reach out regarding the opportunity to take part in a class action lawsuit against the company. The deadline to register for this class action is set for September 12, 2025.

Understanding the Class Action Allegations

The class action complaint asserts that during the defined class period from March 24, 2023, to May 14, 2025, the defendants issued false and misleading information regarding the company’s product candidates. The spokesperson from The Gross Law Firm indicated several critical issues at stake:
1. Exaggerated Claims on Product Candidates: Allegations suggest that Biohaven overstated the regulatory prospects for its product candidate, troriluzole, as a treatment for specified conditions. Furthermore, the data that were submitted for regulatory approval may not have been sufficient, leading to significant misrepresentation.
2. Inflated Efficacy of Treatments: Claims regarding the effectiveness of another product candidate, BHV-7000, for treating bipolar disorder were similarly inflated, subsequently distorting the understanding of its clinical prospects.
3. Potential Negative Impacts: Once these misleading statements are revealed to the public, it may adversely impact Biohaven’s business operations and financial standing, suggesting that the company's value is significantly less than represented.
4. Misrepresentation of Public Statements: The complaint underscores that public statements made by defendants were materially false and misleading throughout the relevant timeframe.

Important Steps for Shareholders

Shareholders who purchased BHVN shares during the stipulated period are strongly encouraged to act swiftly. To register, individuals can fill out a loss submission form accessible via the law firm's website. Enrollment in a portfolio monitoring software will also be provided, enabling shareholders to receive updates about the lawsuit's progress.

It is imperative to note that registration as a lead plaintiff is not obligatory for participating in any potential recovery. This means that shareholders can be a part of the lawsuit without the additional responsibilities that come with the lead plaintiff role.

Why Choose The Gross Law Firm?

The Gross Law Firm possesses a robust reputation as a nationally recognized class action law firm dedicated to safeguarding investors' rights. Their mission revolves around holding companies accountable for deceit and illegal business operations. They emphasize a commitment to ensuring that corporations uphold responsible business practices while supporting corporate accountability.

The firm is especially focused on assisting investors who have encountered losses due to the dissemination of false or misleading information from companies, which can lead to the artificial inflation of stock prices. They remind potential participants that there are no upfront costs or obligations associated with registering for the lawsuit.

Contact Information

For more information or to take action regarding the Biohaven Ltd. class action lawsuit, shareholders can contact The Gross Law Firm directly:

• - Address: 15 West 38th Street, 12th Floor, New York, NY, 10018
• - Phone: (646) 453-8903
• - Email: [email protected]

In light of these developments, it is essential for Biohaven Ltd. shareholders to consider their position and act promptly by the September 12, 2025 deadline. This notice serves as a reminder of the importance of strong investor rights protection and the legal recourse available to those who have been misled.